Evidence map›Paper›PMID 36755719›Full record

ArticleChemical science2023

Programmable synthesis of well-defined, glycosylated iron(ii) supramolecular assemblies with multivalent protein-binding capabilities.

Jake H Schwab, Jake B Bailey, Milan Gembicky, Julia M Stauber

Abstract read
In one paragraph

Article in Chemical science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jake H SchwabDepartment of Chemistry and Biochemistry, University of California 9500 Gilman Dr, La Jolla San Diego CA USA jstauber@ucsd.edu.ORCID https://orcid.org/0000-0001-6663-9542
Jake B BaileyDepartment of Chemistry and Biochemistry, University of California 9500 Gilman Dr, La Jolla San Diego CA USA jstauber@ucsd.edu.
Milan GembickyDepartment of Chemistry and Biochemistry, University of California 9500 Gilman Dr, La Jolla San Diego CA USA jstauber@ucsd.edu.ORCID https://orcid.org/0000-0002-3898-1612
Julia M StauberDepartment of Chemistry and Biochemistry, University of California 9500 Gilman Dr, La Jolla San Diego CA USA jstauber@ucsd.edu.ORCID https://orcid.org/0000-0001-9783-907X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multivalency plays a key role in achieving strong, yet reversible interactions in nature, and provides critical chemical organization in biological recognition processes. Chemists have taken an interest in designing multivalent synthetic assemblies to both better understand the underlying principles governing these interactions, and to build chemical tools that either enhance or prevent such recognition events from occurring in biology. Rationally tailoring synthetic strategies to achieve the high level of chemical control and tunability required to mimic these interactions, however, is challenging. Here, we introduce a systematic and modular synthetic approach to the design of well-defined molecular multivalent protein-binding constructs that allows for control over size, morphology, and valency. A series of supramolecular mono-, bi-, and tetrametallic Fe(ii) complexes featuring a precise display of peripheral saccharides was prepared through coordination-driven self-assembly from simple building blocks. The molecular assemblies are fully characterized, and we present the structural determination of one complex in the series. The mannose and maltose-appended assemblies display strong multivalent binding to model lectin, Concanavalin A (

Identifiers

PMID36755719
PMCPMC9890585

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.